Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.

Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinical disease in immunocompromised individuals, such as organ transplant recipients and infants infected in utero. Antiviral chemotherapy remains problematic due to toxicity of the available compounds and the eme...

Full description

Bibliographic Details
Main Authors:	Anna Bootz, Astrid Karbach, Johannes Spindler, Barbara Kropff, Nina Reuter, Heinrich Sticht, Thomas H Winkler, William J Britt, Michael Mach
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-08-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC5595347?pdf=render

Similar Items

Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.
by: Barbara Kropff, et al.
Published: (2012-01-01)

Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
by: Nina Reuter, et al.
Published: (2022-01-01)

The Autonomous Fusion Activity of Human Cytomegalovirus Glycoprotein B Is Regulated by Its Carboxy-Terminal Domain
by: Nina Reuter, et al.
Published: (2024-09-01)

B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.
by: Sonja Pötzsch, et al.
Published: (2011-08-01)

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies
by: Baraniak, Ilona, et al.
Published: (2018)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
by: Miho Shibamura, et al.
Published: (2020-08-01)

Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes
by: Julia Kalser, et al.
Published: (2017-08-01)

Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
by: Li He, et al.
Published: (2022-07-01)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B.
by: Miwa Okamoto, et al.
Published: (2023-01-01)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
by: Yuanbao Ai, et al.
Published: (2022-12-01)

IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus
by: Siddiqui, Saima, et al.
Published: (2020)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
by: Hailee R. Perrett, et al.
Published: (2023-05-01)

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
by: Junping Hong, et al.
Published: (2022-05-01)

Human Cytomegalovirus Envelope Protein gpUL132 Regulates Infectious Virus Production through Formation of the Viral Assembly Compartment
by: Hui Wu, et al.
Published: (2020-10-01)

Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas
by: Takako Tabata, et al.
Published: (2019-09-01)

Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
by: Andrea J. Parsons, et al.
Published: (2022-04-01)

Characterization of Single-Chain Fv Fragments of Neutralizing Antibodies to Rabies Virus Glycoprotein
by: Kohei Yumoto, et al.
Published: (2021-11-01)

In Silico Analysis of Neutralizing Antibody Epitopes on The Hepatitis C Virus Surface Glycoproteins
by: Raziyeh Zareh-Khoshchehreh, et al.
Published: (2023-01-01)

Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40
by: Dong-Shan Yu, et al.
Published: (2018-10-01)

Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop
by: Charles D. Murin, et al.
Published: (2018-09-01)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
by: Benjamin M. Janus, et al.
Published: (2018-09-01)

Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.
by: S Gnanakaran, et al.
Published: (2010-01-01)

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.
by: Michael W Grunst, et al.
Published: (2023-05-01)

Study on thedistribution of high titer neutralizing antibody against human cytomegalovirus in plasma donors
by: Junying SHEN, et al.
Published: (2022-01-01)

A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
by: Yuting Zhang, et al.
Published: (2024-03-01)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
by: Shilei Ding, et al.
Published: (2020-10-01)

An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein
by: Andrew I Flyak, et al.
Published: (2020-03-01)

Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells
by: Felix Wussow, et al.
Published: (2017-10-01)

Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
by: Wright, D, et al.
Published: (2020)

Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
by: El-Shenawy Reem, et al.
Published: (2011-08-01)

Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein
by: Jan Hellert, et al.
Published: (2020-01-01)

Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
by: Daniel Wright, et al.
Published: (2020-11-01)

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
by: Daiyin Tian, et al.
Published: (2017-11-01)

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
by: Katie A. Howell, et al.
Published: (2017-04-01)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
by: Claudia Gandolfo, et al.
Published: (2021-08-01)

Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention
by: Juan C Becerra, et al.
Published: (2024-07-01)

Isolation of Neutralizing Antibody
by: Mayo Yasugi, et al.
Published: (2013-12-01)

HCMV Infection of Human Trophoblast Progenitor Cells of the Placenta Is Neutralized by a Human Monoclonal Antibody to Glycoprotein B and Not by Antibodies to the Pentamer Complex
by: Martin Zydek, et al.
Published: (2014-03-01)

A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns
by: Ana Chumbe, et al.
Published: (2024-03-01)

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
by: Landolfo Santo, et al.
Published: (2008-11-01)